Martínez HD, Gamboa CM, Hernández GL, Torres MRM, Torres TTC, Camiño AK

Language: Spanish
References: 0
Page: 1-9
PDF size: 356.44 Kb.

ABSTRACT

Introduction: Prostatic hyperplasia is a common disease in elderly male patients and the most frequent cause of obstructive symptoms of the lower urinary tract. The standard for its surgical treatment has been transurethral resection, which is not one without complications. Objective: To describe the complications of transurethral resection of the prostate at the National Center for Minimal Access Surgery. Methods: A retrospective, descriptive and cross-sectional study was conducted between March 2020 and February 2022, at the National Center for Minimal Access Surgery, in a series of 27 patients with prostatic hyperplasia, operated on of prostate´s transurethral resection. The main variables were the prostate volume estimated by sonography, the presence of complications and their degree of severity, the need for reoperation. Descriptive statistics were used. Results: The mean age of the patients was 65.3 years. ASA II predominated (59.2%) and hypertension and diabetes mellitus among comorbidities. The prostatic volume and mean prostatic antigen were 50.2 ml and 2.5 ng/ml, respectively. There were no intraoperative complications and 18.5% had postoperative complications. Bleeding predominated (11.1%), mostly grade II, according to Clavien-Dindo (14.8%). The hospital stay was 3.2 days. Three patients (11.1%) required re-admission. One patient was infected with COVID-19. Conclusions: Prostatic TUR was a safe surgical technique, with a low percentage of complications of little severity.